Stock Events

Stock Events

EyePoint 

$4.58
48
+$0.01+0.33% Friday 19:59
-$0.01-0.22%Friday 23:46After hours

Statistics

Day High
4.68
Day Low
4.51
52W High
19.11
52W Low
3.95
Volume
59,122
Avg. Volume
-
Mkt Cap
394.85M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.09
-0.89
-0.69
-0.49
Expected EPS
-0.905228
Actual EPS
N/A

Financials

-739.42%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
31.37MRevenue
-231.96MNet Income

Analyst Ratings

25.25Average Price Target
The highest estimate is 68.00.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EYPT. It's not an investment recommendation.
NVIDIA
13
NVDA
AMD
8
AMD
Apple
7
AAPL
Lilly(Eli) &
7
LLY

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals competes in the ophthalmology space with treatments for eye diseases, directly competing with EyePoint's eye disease products.
Novartis
NVSEF
Mkt Cap293.18B
Novartis AG, through its acquisition of Alcon, offers a range of eye care products, including pharmaceuticals for chronic eye diseases, competing in the same market as EyePoint.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie, after acquiring Allergan, has a strong presence in the eye care market, especially with products treating eye conditions like dry eye, directly competing with EyePoint's portfolio.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG, with its ophthalmology division, develops treatments for eye diseases such as macular degeneration, competing with EyePoint's disease-targeting treatments.
Bausch Health Companies
BHC
Mkt Cap2.36B
Bausch Health Companies, through its eye health division, offers products for various eye conditions, competing in the same space as EyePoint Pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its Vision Care division, provides products for eye health, including pharmaceuticals, competing with EyePoint's offerings.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. has a portfolio of ophthalmology drugs treating conditions like glaucoma, directly competing with EyePoint Pharmaceuticals in the eye care market.
Biogen
BIIB
Mkt Cap32.28B
Biogen Inc. has ventured into ophthalmology with treatments for eye diseases, representing a competitive presence in the market for EyePoint Pharmaceuticals.

About

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
Show more...
CEO
Jay S. Duker
Employees
214
Country
United States
ISIN
US30233G2093
WKN
000A2QJRU

Listings

STU
DE
PV3B.STU
MU
DE
PV3B.MU
XNAS
US
EYPT
F
DE
PV3B.F

0 Comments

Share your thoughts

FAQ

What is EyePoint stock price today?▼
The current price of EYPT is $4.58 USD — it has increased by +0.33% in the past 24 hours. Watch EyePoint stock price performance more closely on the chart.
What is EyePoint stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange EyePoint stocks are traded under the ticker EYPT.
Is EyePoint stock price growing?▼
EYPT stock has risen by +2.23% compared to the previous week, the month change is a -62.61% fall, over the last year EyePoint has showed a -67.31% decrease.
What is EyePoint market cap?▼
Today EyePoint has the market capitalization of 394.85M
When is the next EyePoint earnings date?▼
EyePoint is going to release the next earnings report on November 04, 2026.
What were EyePoint earnings last quarter?▼
EYPT earnings for the last quarter are -1.09 USD per share, whereas the estimation was -1.01 USD resulting in a -8% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is EyePoint revenue for the last year?▼
EyePoint revenue for the last year amounts to 31.37M USD.
What is EyePoint net income for the last year?▼
EYPT net income for the last year is -231.96M USD.
How many employees does EyePoint have?▼
As of September 05, 2026, the company has 214 employees.
In which sector is EyePoint located?▼
EyePoint operates in the Health & Wellness sector.
When did EyePoint complete a stock split?▼
The last stock split for EyePoint was on December 09, 2020 with a ratio of 1:10.
Where is EyePoint headquartered?▼
EyePoint is headquartered in WATERTOWN, United States.